We provide evidence that FNDC4 acts as an endocrine factor, which controls systemic glucose tolerance and responds to insulin-sensitizing treatments such as diet, exercise, or BS in conjunction with the reversal of T2D and improvements in insulin resistance in mice and humans. Here, INS is linked to Insulin resistance.